HOME >> MEDICINE >> NEWS
NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks

nue for up to seven years.

The research structure resulting from this competition will enable NIAID's Division of AIDS to more effectively respond to global research needs, including those of people of color, those who live in poverty, and women, all of whom are increasingly affected by the HIV/AIDS pandemic and continue to be under-represented in clinical research.

"We are pleased to be making this announcement on World AIDS Day," says Dr. Fauci, "as this year's World AIDS Day theme focuses on 'Women, Girls, HIV and AIDS'."

Each network leadership group selected as part of this competition will work with NIAID and other NIH Institutes on a focused research effort. To most effectively coordinate across disciplines, each network can address significant scientific questions in one or more of six priority research areas

  • Developing HIV vaccines
  • Translating research insights into therapeutic products to treat HIV disease
  • Optimizing clinical management of HIV/AIDS, including co-infections and other HIV-related conditions
  • Developing microbicides to prevent HIV acquisition and transmission
  • Preventing mother-to-child transmission of HIV
  • Developing other methods of HIV prevention

    The decision to revamp the clinical research structure emerged following extensive consultations with researchers, clinicians, community, nurses, advocates and people living with and at risk for HIV/AIDS. The new approach is designed to increase the efficiency, accountability and integration of NIAID's HIV/AIDS clinical research networks and enhance their capacity to effectively conduct vital clinical research, especially in resource-limited settings. Specifically, the new clinical research structure will

  • Maximize scientific opportunities by integrating and coordinating HIV/AIDS prevention, vaccine and therapeutic research and maintaining a flexible and responsive approach to emerg
    '"/>


  • Contact: NIAID Press Office
    niaidnews@niaid.nih.gov
    301-402-1663
    NIH/National Institute of Allergy and Infectious Diseases
    1-Dec-2004


    Page: 1 2 3

    Related medicine news :

    1. NIAID initiates trial of experimental avian flu vaccine
    2. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
    3. NIAID begins enrolling volunteers for novel HIV vaccine study
    4. NIAID-sponsored clinical trial aims to boost flu vaccine supply
    5. NIAID launches influenza genome sequencing project
    6. NIAID launches program to improve medical tools against emerging infectious diseases
    7. NIAID forms network to tackle potentially fatal reaction to smallpox vaccine
    8. NIAID rotavirus vaccine licensed for commercialization
    9. Second NIAID SARS vaccine candidate helps mice fend off SARS
    10. NIAID vaccine protects against SARS virus infection in mice
    11. NIAID Ebola vaccine enters human trial

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:12/2/2016)... ... December 02, 2016 , ... Lori G. Cohen and Sara ... speak at the American Conference Institute’s 21st Drug & Medical Device Litigation Conference ... Sponsor of the conference. , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & ...
    (Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, ... Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who have made a ... going above and beyond the standard of care, demonstrating leadership within the MPN community ...
    (Date:12/2/2016)... ... December 02, 2016 , ... More than ... Alabama are expected to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. ... for area students and operating support to UNCF-member institutions, including Miles College, Oakwood ...
    (Date:12/2/2016)... California (PRWEB) , ... December 02, 2016 , ... ... professionals, proudly announces the launch of its 60-day free trial program for all ... trip shipping make the offer a truly hassle free experience. , FlexiSpot’s unique ...
    (Date:12/2/2016)... NC (PRWEB) , ... December 02, 2016 , ... The ... Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries ... (Part C) or prescription drug plan (Part D) need to make changes during this ...
    Breaking Medicine News(10 mins):
    (Date:12/2/2016)... , Dec. 2, 2016  LifeVac, the revolutionary device ... in the Emergency Response Training and Support Services (ERTSS) ... to have LifeVac become part of the ERTSS mission ... and CEO of LifeVac. "Having an established network of ... effectively will help leverage our efforts to spread LifeVac,s ...
    (Date:12/2/2016)... Research and Markets has announced the addition of the ... 2022" report to their offering. ... , The global ultrasound device ... expected to grow at a CAGR of 5.5% during 2016-2022. Based on ... the forecast period, a CAGR of 8.8% in the global market. Among ...
    (Date:12/2/2016)... Dec. 2, 2016 Quantum Radiology,s Mobile Breast ... radiologist interpretation directly to women at the workplace, thereby ... such as Delta Air Lines and SunTrust Bank, and ... a component of wellness initiatives. "I think ... It enables them to have a mammogram without taking ...
    Breaking Medicine Technology:
    Cached News: